LONDON, United Kingdom (AFP) — The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain, according to research reported in the Financial Times. But in its study, due to be published Monday, the pharma group said it could still have an effect on severe disease — although there is not yet enough data to make a definitive judgement. None of the 2,000 participants in the trial developed serious […]